A Potential Administration-time Dependent Effect of Bevacizumab in
Improving Overall Survival and Increasing Metastasis in Metastatic
Colorectal Cancer
3Tumor Center, The Foshan First People’s Hospital, Foshan, P.R. China
#Contributed equally to this work
*Corresponding Author:
Liangping Xia, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China, Tel: +8620-87343107, Fax: +86-20-87343392 Email: